| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028691 |
| Receipt No. | R000032766 |
| Scientific Title | Effectiveness of occupational sleep health guidance on work engagement of workers aware of difficulty sleeping: non-randomized, single arm and time series trial |
| Date of disclosure of the study information | 2017/08/21 |
| Last modified on | 2020/11/07 (Ver. 8) |
| Basic information | ||
| Public title | Effectiveness of occupational sleep health guidance on work engagement of workers aware of difficulty sleeping: non-randomized, single arm and time series trial | |
| Acronym | Effectiveness of occupational sleep health guidance on work engagement | |
| Scientific Title | Effectiveness of occupational sleep health guidance on work engagement of workers aware of difficulty sleeping: non-randomized, single arm and time series trial | |
| Scientific Title:Acronym | Effectiveness of occupational sleep health guidance on work engagement | |
| Region |
|
|
| Condition | ||
| Condition | Healthy industrial population aware of sleep difficulty | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effects of occupational sleep health guidance for workers aware of sleep difficulty in work engagement |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Work engagement will be measured by the Japanese short version of the Utrecht work engagement scale (Two months after the start of intervention) |
| Key secondary outcomes | 1) Quality of sleep by using Pittsburgh sleep quality index, Japanese Version (Two months after the start of intervention)
2) Work performance by WHO health and work performance questionnaire (short form) Japanese edition (Two months after the start of intervention) 3) Depression by the center for epidemiologic studies depression scale (Two months after the start of intervention) 4) Support resources by analyzing usage status of support resources related to sleep (Two months after the start of intervention) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | We conduct occupational sleep guidance based on cognitive behavioral therapy for insomnia, and we added the two points: assessment of symptom occurrence or exacerbation factors and viewpoint of psychosocial problem solving. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Employees of companies in Japan
2) Those who do not plan to retire within six months 3) Those who are aware of at least one insomnia symptom (difficulty falling asleep, arousal during sleep, early-morning awakening, the lack of a deep sleep feeling ) 4) Those who can participate in the trial for four months including two months non-intervention period and two months intervention period, and twice 30 minutes personal interview (the first time and one month after starting) 5) Those who can consent about the study by documents. |
|||
| Key exclusion criteria | 1) Those who are presumed to be unable to understand and complete the purpose of this study because of their physical and mental disabilities
2) Those who the research staff judges that he/she is inappropriate for participation in this study |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hiroshima University | ||||||
| Division name | Graduate School of Biomedical & Health Sciences | ||||||
| Zip code | 734-8553 | ||||||
| Address | Kasumi 1-2-3, Minami-ku, Hiroshima, Japan | ||||||
| TEL | +81-82-257-5365 | ||||||
| morimich@hiroshima-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hiroshima University | ||||||
| Division name | Graduate School of Biomedical & Health Sciences | ||||||
| Zip code | 7348553 | ||||||
| Address | Kasumi 1-2-3, Minami-ku, Hiroshima, Japan | ||||||
| TEL | +81-82-257-5367 | ||||||
| Homepage URL | |||||||
| d161682@hiroshima-u.ac.jp | |||||||
| Sponsor | |
| Institute | Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University Grants |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hiroshima University |
| Address | Kasumi 1-2-3 Minami-ku, Hiroshima, Japan |
| Tel | +81822575367 |
| d161682@hiroshima-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | ||
| URL related to results and publications | ||
| Number of participants that the trial has enrolled | 100 | |
| Results | ||
| Results date posted | ||
| Results Delayed |
|
|
| Results Delay Reason | Currently, preparing a result paper. | |
| Date of the first journal publication of results | ||
| Baseline Characteristics | ||
| Participant flow | ||
| Adverse events | ||
| Outcome measures | ||
| Plan to share IPD | ||
| IPD sharing Plan description | ||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032766 |